New Treatment for Hereditary Blindness Possible Using Nanoparticles and mRNA

Scientists from the Oregon State University College of Pharmacy have demonstrated in animal models the possibility of using lipid nanoparticles and messenger RNA, the technology underpinning COVID-19 vaccines, to treat blindness associated with a rare genetic condition.